Invention Grant
US07928227B2 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
失效
可用于治疗高增殖性，血管生成和炎症性疾病的2-氧代-1,3,5-三氢三氮杂衍生物
- Patent Title: 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
- Patent Title (中): 可用于治疗高增殖性，血管生成和炎症性疾病的2-氧代-1,3,5-三氢三氮杂衍生物
-
Application No.: US10788405Application Date: 2004-03-01
-
Publication No.: US07928227B2Publication Date: 2011-04-19
- Inventor: Stephen Boyer , Jacques Dumas , Barton Phillips , William J. Scott , Roger A. Smith , Jianqing Chen , Benjamin Jones , Gan Wang
- Applicant: Stephen Boyer , Jacques Dumas , Barton Phillips , William J. Scott , Roger A. Smith , Jianqing Chen , Benjamin Jones , Gan Wang
- Applicant Address: US NY Tarrytown
- Assignee: Bayer Healthcare LLC
- Current Assignee: Bayer Healthcare LLC
- Current Assignee Address: US NY Tarrytown
- Agency: Millen, White, Zelano & Branigan, P.C.
- Main IPC: C07D251/08
- IPC: C07D251/08 ; C07D401/04 ; C07D401/14 ; C07D403/04 ; C07D403/14 ; A61K31/53 ; A61P19/02
Abstract:
This invention relates to novel diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.
Public/Granted literature
Information query
